1 Introduction 9

• 1.1 Industry Definition and Research Scope 9
  • 1.1.1 Industry Definition 9
  • 1.1.2 Research Scope 10
• 1.2 Research Methodology 13
  • 1.2.1 Overview of Market Research Methodology 13
  • 1.2.2 Market Assumption 14
  • 1.2.3 Secondary Data 14
  • 1.2.4 Primary Data 14
  • 1.2.5 Data Filtration and Model Design 15
  • 1.2.6 Market Size/Share Estimation 16
  • 1.2.7 Research Limitations 17
• 1.3 Executive Summary 18

2 Market Overview and Dynamics 21

• 2.1 Market Size and Forecast 21
  • 2.1.1 Impact of COVID-19 on World Economy 22
  • 2.1.2 Impact of COVID-19 on the Market 26
• 2.2 Major Growth Drivers 28
• 2.3 Market Restraints and Challenges 36
• 2.4 Emerging Opportunities and Market Trends 39
• 2.5 Porter’s Fiver Forces Analysis 43

3 Segmentation of Global Market by Offering 47

• 3.1 Market Overview by Offering 47
• 3.2 Products 49
  • 3.3.1 Probiotics 50
  • 3.3.2 Prebiotics 51
  • 3.3.3 Vitamins & Supplements 52
• 3.3 Testing Services 53
  • 3.3.1 Nutrigenomics Clinical Testing 54
  • 3.3.2 Nutrigenomics Research Testing 55

4 Segmentation of Global Market by Test Technology 56

• 4.1 Market Overview by Test Technology 56
• 4.2 Next-generation Sequencing 58
• 4.3 Real-time PCR 59
• 4.4 DNA Microarray 60
• 4.5 Sanger Sequencing 61

5 Segmentation of Global Market by Test Sample 62

• 5.1 Market Overview by Test Sample 62
• 5.2 Buccal Swab Sample 64
• 5.3 Saliva Sample 65
• 5.4 Blood Sample 66
• 5.5 Other Samples 67

6 Segmentation of Global Market by Application 68

• 6.1 Market Overview by Application 68
• 6.2 Women’s Health 70
• 6.3 Metabolic Disorders 71
• 6.4 Immune Health 72
• 6.5 Cancer Research 73
• 6.6 Cardiovascular Diseases 74
• 6.7 Diabetes 75
• 6.8 Other Applications 76

7 Segmentation of Global Market by End User 77

• 7.1 Market Overview by End User 77
• 7.2 Hospitals 79
• 7.3 Nutrition Clinics 80
• 7.4 Diagnostics Laboratories 81
• 7.5 Other End Users 82

8 Segmentation of Global Market by Region 83

• 8.1 Geographic Market Overview 2021-2031 83
• 8.2 North America Market 2021-2031 by Country 87
  • 8.2.1 Overview of North America Market 87
  • 8.2.2 U.S. 91
  • 8.2.3 Canada 94
  • 8.2.4 Mexico 96
• 8.3 European Market 2021-2031 by Country 98
  • 8.3.1 Overview of European Market 98
  • 8.3.2 Germany 102
  • 8.3.3 U.K. 104
  • 8.3.4 France 106
  • 8.3.5 Spain 108
  • 8.3.6 Italy 110
  • 8.3.7 Netherlands 112
  • 8.3.8 Rest of European Market 114
• 8.4 Asia-Pacific Market 2021-2031 by Country 116
  • 8.4.1 Overview of Asia-Pacific Market 116
  • 8.4.2 Japan 120
  • 8.4.3 China 123
  • 8.4.4 Australia 125
  • 8.4.5 India 127
  • 8.4.6 South Korea 129
  • 8.4.7 Rest of APAC Region 131
• 8.5 South America Market 2021-2031 by Country 133
  • 8.5.1 Argentina 136
  • 8.5.2 Brazil 138
  • 8.5.3 Chile 140
  • 8.5.4 Rest of South America Market 142
• 8.6 MEA Market 2021-2031 by Country 143
  • 8.6.1 UAE 146
  • 8.6.2 Saudi Arabia 148
  • 8.6.3 South Africa 150
  • 8.6.4 Other National Markets 152

9 Competitive Landscape 153

• 9.1 Overview of Key Vendors 153
• 9.2 New Product Launch, Partnership, Investment, and M&A 157
• 9.3 Company Profiles 158

BASF SE 158

BioGaia 160

Cell Logic 161

Cura Integrative Medicine 162

DNAfit 163

DuPont de Nemours, Inc. 164

Garden of Life, LLC 165

GeneOmbio 166

Genova Diagnostics, Inc. 167

GX Sciences, Inc. 168

Ingredion Incorporated 169

Jarrow Formulas Inc. 170

Koninklijke DSM N.V. 171

MedGenome 172

Metagenics, Inc. 173

Nutrigenomix Inc. 174

Unilever Group 175

XCODE Life 176

Yakult Honsha Co., Ltd. 177

RELATED REPORTS 178

Global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.
Highlighted with 86 tables and 91 figures, this 178-page report “Global Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Region.

Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Products
o Probiotics
o Prebiotics
o Vitamins & Supplements
• Testing Services
o Nutrigenomics Clinical Testing
o Nutrigenomics Research Testing

Based on Test Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Next-generation Sequencing
• Real-time PCR
• DNA Microarray
• Sanger Sequencing

By Test Sample, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Buccal Swab Sample
• Saliva Sample
• Blood Sample
• Other Samples

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Women’s Health
• Metabolic Disorders
• Immune Health
• Cancer Research
• Cardiovascular Diseases
• Diabetes
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Nutrition Clinics
• Diagnostics Laboratories
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Offering，Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)